Afasizhev & Afasizheva Labs - Researched mitochondrial RNA processing and editing mechanisms in Trypanosoma brucei to elucidate gene expression pathways.
Executed cloning and plasmid preparation for advanced genetic studies.
Purified mitochondrial proteins to enable detailed analysis.
Conducted transfection-based tagging of Trypanosoma brucei proteins, confirming results through Western blot.
Clinical Volunteer
Boston Specialists
Boston, MA
01.2025 - Current
Facilitated patient intake, appointment scheduling, and data entry between NexHealth and eClinicalWorks systems.
Supported clinical procedures such as oral food challenges and aeroallergen skin prick testing.
Monitored patient vitals to ensure accurate health assessments.
Coordinated with pharmacists for timely medication delivery.
Student Researcher
Lumiere Education
Shanghai, Boston
05.2024 - Current
Authored publication-ready manuscript titled Bacteriophages: Remedy to Antibiotic Resistance? Submitted to Journal of Young Investigators, awaiting acceptance.
Conducted comprehensive literature review of scientific journals and experimental studies on bacteriophage therapy.
Integrated theoretical, experimental, and clinical perspectives to advocate for global phage therapy adoption.
Explored innovative strategies to enhance treatment efficacy while addressing medical implementation challenges.
Medical Intern
AstraZeneca
Shanghai, China
06.2024 - 09.2024
Shadowed and assisted the endocrinology sales team promoting Forxiga® (dapagliflozin) and Kombiglyze XR® (saxagliptin/metformin) to physicians in public hospitals.
Helped organize regional symposia and physician education events on type 2 diabetes and heart failure.
Studied SGLT2 and DPP-4 inhibitors, noting Forxiga’s role in glucose excretion and cardio-renal benefits, and how Kombiglyze XR modulates incretin pathways for glycemic control.
Extern at Harvard University-School of Dental Medicine/Boston Children’s HospitalExtern at Harvard University-School of Dental Medicine/Boston Children’s Hospital